Kalion Revenue and Competitors

Milton, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Kalion's estimated annual revenue is currently $1.7M per year.(i)
  • Kalion's estimated revenue per employee is $155,000

Employee Data

  • Kalion has 11 Employees.(i)
  • Kalion grew their employee count by -8% last year.

Kalion's People

NameTitleEmail/Phone
1
Chief ScientistReveal Email/Phone
2
VP Product DevelopmentReveal Email/Phone
3
VP business DevelopmentReveal Email/Phone
4
PresidentReveal Email/Phone
5
Research ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Kalion?

Kalion was founded to take on the significant challenge of commercializing important new molecules that could be derived in a greener manner and offer significant advantages over traditional oil-based molecules. Prof. Kristala Prather at MIT decided using the Department of Energy's Top Value-Added Chemical from Biomass Report that glucaric acid offered a significant challenge but if successful it could offer a new platform chemical that could would have much to offer the world. Her success, with glucaric acid and the subsequent development at Kalion has created a high purity glucaric acid that now allows companies and researchers from other universities to fully exploited the unique properties of glucaric acid and related molecules.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Kalion News

2022-04-17 - Global Glucuronic Acid Market Trends, Status and Future ...

Anhui Hegeng Biology, Kalion, Beijing Chemsynlab, Shanghai Meng Yabio, Guangzhou Roles-Bio, Shanghai Baomanbio.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M11N/AN/A
#2
$2.4M120%N/A
#3
$1M12-25%N/A
#4
N/A130%N/A
#5
$2.1M13-19%N/A